Stage 3 Cancer: Definition, Diagnosis, Treatment, Prognosis
til therapy :: Article Creator TIL Therapy For Non-Small Cell Lung Cancer May Be Effective There is evidence that an emerging type of immunotherapy called TIL therapy may be successful in treating more solid tumors. Research published in Cancer Discovery shows this treatment works in some patients with non-small cell lung cancer. The lead researcher of the multicenter clinical trial was Memorial Sloan Kettering Cancer Center (MSK) lung cancer specialist Adam Schoenfeld, MD. "The patients who came to us in this trial were very sick and had often exhausted all other options," says Dr. Schoenfeld, a thoracic oncologist, cellular therapist, and early drug development specialist. "The fact that 21% of the non-small cell lung cancer patients responded to TIL therapy is significant. Some patients remained free of cancer relapse for more than two years after the treatment." TIL Therapy Clinical Trial Results for Non-Small Cell Lung